ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Nandrolone Survey: Please Participate
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Guided_by_Voices" data-source="post: 187930" data-attributes="member: 15235"><p>I'd like to participate, but why is this limited to Deca and excludes NPP? I know that NPP is easily available in fewer regions, however given the (anecdotal but widely reported) reduction in side effects from NPP as well as the generally lower risk profile of shorter esters (at least for new users) I would think that one of the most important potential aspects of increasing the low-risk use of Nandrolone would be to generate data to make the case that NPP should be more widely available. Also, if Nandrolone is ever going to be viable for users not on TRT, I would think the intermittent nature of NPP would be less suppressive and a much better option. I think it is unfortunate that so many people treat the Deca version of Nandrolone as synonymous with all Nandrolone, which is an overly US-centric view.</p></blockquote><p></p>
[QUOTE="Guided_by_Voices, post: 187930, member: 15235"] I'd like to participate, but why is this limited to Deca and excludes NPP? I know that NPP is easily available in fewer regions, however given the (anecdotal but widely reported) reduction in side effects from NPP as well as the generally lower risk profile of shorter esters (at least for new users) I would think that one of the most important potential aspects of increasing the low-risk use of Nandrolone would be to generate data to make the case that NPP should be more widely available. Also, if Nandrolone is ever going to be viable for users not on TRT, I would think the intermittent nature of NPP would be less suppressive and a much better option. I think it is unfortunate that so many people treat the Deca version of Nandrolone as synonymous with all Nandrolone, which is an overly US-centric view. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Nandrolone Survey: Please Participate
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top